Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5614631 | 0.94 | — | — | |
| SCHEMBL5614835 | 0.94 | — | — | |
| SCHEMBL5609881 | 0.92 | — | — | |
| SCHEMBL5614463 | 0.91 | ELANE (0.32) | ELANECTSG | |
| SCHEMBL5614398 | 0.91 | — | — | |
| SCHEMBL5614399 | 0.91 | — | — | |
| SCHEMBL5608914 | 0.89 | ELANE (0.30) | ELANECTSG | |
| SCHEMBL5609552 | 0.89 | — | — | |
| SCHEMBL5608993 | 0.89 | ELANE (0.31) | ELANECTSG | |
| SCHEMBL5614983 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7157591-B2 | Metallocenes and catalyst compositions derived therefrom | EXXONMOBIE CHEMICAL PATENTS INC. (US) | 2007-01-02 | — | — | US | disclosed |
| US-20050037919-A1 | Metallocenes and catalyst compositions derived therefrom | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-02-17 | — | — | US | disclosed |
| EP-1456217-A1 | METALLOCENES AND CATALYST COMPOSITIONS DERIVED THEREFROM | Exxonmobil Chemical Patents Inc. (US) | 2004-09-15 | — | — | EP | disclosed |
| WO-2003050131-A1 | METALLOCENES AND CATALYST COMPOSITIONS DERIVED THEREFROM | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2003-06-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050037919-A1 | Metallocenes and catalyst compositions derived therefrom | HMOX1, RTF1, OPRM1 | ELANE 1346/4885CTSG 1362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.